MHRA warns semaglutide users of ‘very rare’ risk of vision loss

"It is important that patients are alert to these symptoms” (Shutterstock)
Molly Bowcott

Read more by Molly Bowcott

Molly Bowcott joined C+D as a digital reporter in October 2024 after graduating from a master’s in journalism at City, University of London. She previously worked as a news reporter at the U.S. Sun, covering business, politics and money.

Latest from Clinical

More from News